Loma Linda Pharmacy Dean On The Johnson & Johnson Vaccine, Rare Blood Clots, And More

On Friday, the Food and Drug Administration ended their ten-day pause on use of the Johnson & Johnson COVID-19 vaccine, which came about after six women developed blood clots after taking it. The rare but serious side effect has created unease around the single-shot vaccine, but experts say the risk of developing blood clots from it is extremely low. Dr. Michael Hogue, Dean of the Loma Linda University School of Pharmacy, spoke with KVCR's Benjamin Purper about the Johnson & Johnson vaccine and what he says is the dire need for everyone to get vaccinated against COVID-19.